BLO Cannabix Technologies Inc

Cannabix Achieves New Plateau with its FAIMS Marijuana Breathalyzer Technology

Cannabix Achieves New Plateau with its FAIMS Marijuana Breathalyzer Technology
EN
05/10/2020

Underlying

BLOCannabix Technologies Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabix Technologies Inc

 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT...

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement, is pleased to announce the commercial delivery of its Marijuana Breath Test (“MBT”) products to a leading industrial manufacturing company with operations in the state of Virginia. The delivery was completed t...

April 1, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies Announces Commercial Launch of Marijuana Breath ...

Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) is pleased to announce the commencement of its commercial phased rollout of the Marijuana Breath Test (“MBT”) system. This phase includes the delivery of MBT units to select commercial customers across multiple industries, followed by a planned scale-up in production. The Marijuana Breath Test fills a critical gap and delivers new technology and m...

March 16, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Journal of Analytical Toxicology Publishes Peer-Reviewed Validation St...

Journal of Analytical Toxicology Publishes Peer-Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories’ Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies’ Breath Collection Unit VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories Inc (“Omega”) proudly announce the peer-reviewed publication of a groundbreaking study published by Oxford University Press in the prestigious Journal of Analytical Toxicology titled...

March 3, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies Closes Non-Brokered Private Placement

Cannabix Technologies Closes Non-Brokered Private Placement NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company” or “Cannabix”) announces it has closed its previously announced non-brokered private placement financing (the "Offering") with the issuance of 1,400,000 units of the Company (the “Units”) at an issue price of CDN$0.50 per Unit for aggregate gross proceeds of CDN$700,000. Each Unit consists of one common share in the ca...

February 24, 2026 1 EN
 PRESS RELEASE
Free
BLO Cannabix Techno...

Cannabix Technologies announces Non-Brokered LIFE Private Placement

Cannabix Technologies announces Non-Brokered LIFE Private Placement   NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of a minimum of 1,000,000 and up to 2,000,000 units (the "Units") at a price of CDN$0.50 per Unit for gross proceeds of a minimum of CDN$500,000 and up to CDN$1,000,000. Each Unit will consist of...

February 7, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch